Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Body armour deal sparks value creation excitement for Avon Rubber

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Investors are excited about the potential of increased earnings and substantial costs savings after Avon Rubber (AVON) unveiled a long-mooted US acquisition.
On 7 August the £535m defence technology company announced plans to acquire the ballistic protection business from US specialist materials conglomerate 3M, including the rights to the Ceradyne brand, which makes body armour and helmets for the US military.
The acquisition will cost $91m with up to an extra $25m payable depending on the outcome of various legacy product contract tenders. The deal will be funded out of existing cash and borrowing facilities.
This is a deal that some analysts have been watching and waiting for 18 months to happen, but it is only during the past week that the full scope for financial benefits to Avon Rubber have appeared in updated forecasts.
‘This is a quality acquisition that surpasses our expectations both strategically and financially, and drives our 20% to 34% earnings upgrades,’ said Berenberg’s capital goods and engineering team.
Berenberg’s analysis runs along twin lines. They see the deal widening Avon’s product range, bolstering average content per soldier, deepening its already strong relationship with the US Department of Defence and strengthening its own research and development capability.
But stripping out duplicated costs form a second line of value for Avon Rubber and its’ shareholders down the line. Estimates suggest up to $5m a year of savings can be delivered over the next couple of years from a $10m upfront investment, creating value for investors beyond 2020.
Beyond these calculations there is also thought to be considerable scope to cross-sell Ceradyne products to Avon’s customers outside of the US, where Ceradyne currently earns more than 90%
of its revenues.
The market was quick to react to the implied benefits to the Avon investment case, with the company’s share price jumping 19% from £13.24 to £15.72 on the day that the acquisition was announced. In the days since then the stock has continued to rally strongly, hitting a record £17.26 on 20 August.
This implies a 31 December 2020 price to earnings multiple of 18.1, falling to 15.5 for the 2021 calendar year.
Berenberg believes that acquisitions are likely to remain a significant part of Avon Rubber’s strategic roadmap in the near-term.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.
Our website uses cookies to give you a better browsing experience.
You can choose to accept all cookies, or control which we use by clicking 'Manage cookies'. To learn more, read our cookie policy.